Security Snapshot

Profound Medical Corp. - Common Shares (PROF) Institutional Ownership

CUSIP: 74319B502

13F Institutional Holders and Ownership History from Q4 2019 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

55

Shares (Excl. Options)

16.05MFull value: 16,054,430 · shares · 30 Jun 2026

Price

$6.65

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Shares
Symbol
PROF on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
16,054,430
Latest holder snapshot 5 signals
Total 13F value
$105,750,145
Portfolio coverage rank
0%
Share change
+45,967
Value change
+$333,207
Number of holders
55
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
29,881,634
SEC-reported price per share
$5.80
Insider filing price
$5.80
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • PROF - Profound Medical Corp. - Common Shares is tracked under CUSIP 74319B502.
  • 55 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 57 to 55 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $105.59MFull value: $105,590,763 · USD · 31 Mar 2026
    to
    $105.75MFull value: $105,750,145 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 55 institutions filings for Q2 2026.

Open SEC evidence

Security key

74319B502

13F reference period

Q2 2026

13F holders

55

13D/G owners

1

CIK / CUSIP context first

Open Q2 2026 holders PROF full holder history Profound Medical Corp. SEC filings Profound Medical Corp. company facts Profound Medical Corp. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
PROF
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GAGNON SECURITIES LLC 11% $15,796,627 3,346,743 Neil Gagnon 31 Dec 2024
As of 30 Jun 2026, 55 institutional investors reported holding
16.05MFull value: 16,054,430 · shares · 30 Jun 2026
shares of Profound Medical Corp. - Common Shares (PROF). This represents 54% of the company’s total
29.88MFull value: 29,881,634 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
52%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FIL Ltd 7.9% 2,370,000 +1.3% 0.01% $15,760,496
GAGNON SECURITIES LLC 6.6% 1,960,074 +0.81% 2.5% $13,034,492
ROYCE & ASSOCIATES LP 4% 1,199,564 +7.5% 0.06% $7,975,948
Timelo Investment Management Inc. 3.7% 1,114,967 0% 9.3% $7,414,531
Gagnon Advisors, LLC 3.2% 962,186 0% 4.1% $6,398,537
LETKO, BROSSEAU & ASSOCIATES INC 3.1% 935,725 -1.8% 0.08% $5,403,226
Rosalind Advisors, Inc. 2.8% 828,118 0% 2.1% $5,506,985
Z3 Capital Partners, LLC 2.7% 820,941 +0.36% 1.1% $5,459,258
MMCAP International Inc. SPC 2.2% 671,356 -9.9% 0.38% $4,464,517
ARDSLEY ADVISORY PARTNERS LP 1.9% 575,000 0% 0.42% $3,823,750
Ring Mountain Capital, LLC 1.7% 511,917 +0.16% 1.4% $3,404,248
Lagoda Investment Management, L.P. 1.7% 501,325 +14% 1.8% $3,333,811
ROYAL BANK OF CANADA 1.6% 491,495 -0.32% 0% $3,268,000
First Eagle Investment Management, LLC 1.5% 440,207 +36% 0% $2,927,377
DAFNA Capital Management LLC 0.87% 260,360 -1% 0.33% $1,731,394
Bleichroeder LP 0.85% 254,753 0% 0.3% $1,694,107
FORMULA GROWTH LTD 0.8% 240,088 -0.44% 0.56% $1,596,585
NATIONAL BANK OF CANADA /FI/ 0.73% 218,698 +0.7% 0% $1,248,927
THOMPSON DAVIS & CO., INC. 0.72% 216,535 +0.35% 0.86% $1,439,958
Dauntless Investment Group, LLC 0.7% 208,369 -13% 2.4% $1,385,654
RAYMOND JAMES FINANCIAL INC 0.63% 189,116 +26% 0% $1,257,622
CM Management, LLC 0.59% 175,000 0% 0.74% $1,163,750
Velan Capital Investment Management LP 0.57% 170,278 -40% 0.69% $1,132,349
TD Waterhouse Canada Inc. 0.46% 138,110 -3.4% 0% $933,554
PERKINS CAPITAL MANAGEMENT INC 0.38% 114,280 0% 0.57% $759,962

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
28
Headline period
Q2 2026
Rows shown
1-25 of 28
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 821,091 $4,712,951 +$249,223 $5.80 7
2026 Q2 16,054,430 $105,750,145 +$333,207 $6.65 55
2026 Q1 16,337,804 $105,590,763 -$569,539 $6.48 57
2025 Q4 16,057,288 $126,309,609 +$31,389,798 $7.87 63
2025 Q3 11,063,194 $54,283,775 -$7,406,922 $4.89 43
2025 Q2 12,482,340 $73,650,616 -$2,042,016 $5.90 44
2025 Q1 12,825,851 $73,303,109 -$7,205,786 $5.82 48
2024 Q4 13,763,555 $102,960,287 +$30,141,003 $7.51 51
2024 Q3 9,406,781 $74,869,184 -$1,117,706 $7.96 42
2024 Q2 9,510,240 $80,047,787 -$132,453 $8.39 37
2024 Q1 9,500,142 $80,114,995 +$2,238,848 $8.53 39
2023 Q4 9,251,176 $77,759,535 +$10,244,275 $8.49 45
2023 Q3 7,489,374 $75,450,155 -$1,487,679 $10.20 30
2023 Q2 7,634,234 $98,724,050 -$1,129,044 $13.01 29
2023 Q1 7,726,121 $71,704,219 -$6,964,776 $9.29 30
2022 Q4 8,472,949 $91,726,796 +$3,083,523 $10.89 33
2022 Q3 8,745,198 $35,381,959 -$177,655 $4.04 30
2022 Q2 8,675,590 $63,032,248 -$3,670,846 $7.29 34
2022 Q1 9,402,835 $84,635,691 -$3,611,432 $9.00 41
2021 Q4 9,774,988 $109,777,858 -$2,915,423 $11.24 44
2021 Q3 8,722,358 $127,589,352 -$1,309,423 $14.64 46
2021 Q2 8,722,951 $142,593,346 -$126,994 $16.36 46
2021 Q1 8,673,835 $174,440,609 +$8,178,699 $20.14 52
2020 Q4 8,182,487 $168,377,436 +$26,332,305 $20.56 53
2020 Q3 7,009,150 $123,510,789 +$42,298,243 $17.64 44
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .